News
9hon MSN
Eli Lilly's oral obesity treatment efficacy falls short of expectations, says BMO's Evan Seigerman
Kelly Clarkson's Ex-Husband Brandon Blackstock Dead At 48 What You're Really Eating When You Order Taco Bell Helicopter ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
21hon MSN
These Stocks Moved the Most Today: Eli Lilly, Fortinet, AppLovin, Sunrun, Airbnb, Duolingo, and More
A slew or company results were causing big market moves ahead of the opening bell Thursday, and for many, earnings-beat ...
U.S. equities slipped midday Thursday as corporate earnings and fresh tariff announcements from President Donald Trump drove ...
Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...
The tariffs are Trump’s way of getting drug companies to move more of their operations to the U.S. at a time when domestic ...
Sales grew 38% year over year, driven by volume growth from weight-loss and diabetes drugs Zepbound and Mounjaro, Lilly said.
Shares of the iPhone maker rose nearly 3%, building on the previous session's rally. Apple announced an extra $100 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback